Balancing Efficacy and Safety: Challenges in Atopic Dermatitis
1. What Are the Latest Developments in Monoclonal Antibody Treatments for Atopic Dermatitis? Monoclonal antibodies have emerged as a game-changer in the treatment of atopic dermatitis, especially for patients with moderate to severe conditions that do not respond well to traditional therapies. In 2024, significant advancements have been made by key industry players like Sanofi...
0 Comentários 0 Compartilhamentos 541 Visualizações 0 Anterior